المؤلفون: Wang SL; Department of Gastroenterology, The First Affiliated Hospital of the University of Science and Technology of China (Anhui Provincial Hospital), Hefei 230001, China., Sun GY; Department of Haematology, The First Affiliated Hospital of the University of Science and Technology of China (Anhui Provincial Hospital), Hefei 230001, China., Zhu XY; Department of Haematology, The First Affiliated Hospital of the University of Science and Technology of China (Anhui Provincial Hospital), Hefei 230001, China., Xu XM; Department of Gastroenterology, The First Affiliated Hospital of the University of Science and Technology of China (Anhui Provincial Hospital), Hefei 230001, China., Ye F; Department of Gastroenterology, The First Affiliated Hospital of the University of Science and Technology of China (Anhui Provincial Hospital), Hefei 230001, China., Li SL; Clinical Pathology Centre, The First Affiliated Hospital of the University of Science and Technology of China (Anhui Provincial Hospital), Hefei 230001, China., Chen S; Department of Gastroenterology, The First Affiliated Hospital of the University of Science and Technology of China (Anhui Provincial Hospital), Hefei 230001, China.

المصدر: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2024 May 14; Vol. 45 (5), pp. 462-467.

نوع المنشور: English Abstract; Journal Article

بيانات الدورية: Publisher: Chinese Medical Association Country of Publication: China NLM ID: 8212398 Publication Model: Print Cited Medium: Print ISSN: 0253-2727 (Print) Linking ISSN: 02532727 NLM ISO Abbreviation: Zhonghua Xue Ye Xue Za Zhi Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease*/etiology , Graft vs Host Disease*/diagnosis , Cord Blood Stem Cell Transplantation* , Colonoscopy*, Humans ; Prognosis ; Retrospective Studies ; Hematologic Neoplasms/therapy ; Female ; Male ; Survival Rate

المؤلفون: Kennedy VE; Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, California. Electronic address: vek@stanford.edu., Sahaf B; Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, California., Wu F; Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, California., Ehlinger ZJ; Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, California., Arai S; Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, California., Miklos DB; Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, California.

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2024 May; Vol. 30 (5), pp. 518.e1-518.e13. Date of Electronic Publication: 2024 Mar 06.

نوع المنشور: Journal Article; Clinical Trial, Phase II; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

مواضيع طبية MeSH: Rituximab*/therapeutic use , Hematopoietic Stem Cell Transplantation*/adverse effects , B-Lymphocytes*/immunology , B-Lymphocytes*/drug effects , Graft vs Host Disease*/prevention & control , Graft vs Host Disease*/immunology , Immune Reconstitution*, Humans ; Female ; Male ; Middle Aged ; Adult ; Transplantation, Homologous/adverse effects ; Treatment Outcome ; Aged ; Follow-Up Studies

المؤلفون: Vijayan V; Division of Critical Care Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA., Yan H; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Lohmeyer JK; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Prentiss KA; Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA., Patil RV; Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA., Barbarito G; Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA., Lopez I; Division of Critical Care Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA., Elezaby A; Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA., Peterson K; Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA., Baker J; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Ostberg NP; Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA., Bertaina A; Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA., Negrin RS; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Mochly-Rosen D; Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA., Weinberg K; Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA., Haileselassie B; Division of Critical Care Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA.

المصدر: Blood advances [Blood Adv] 2024 Jul 23; Vol. 8 (14), pp. 3691-3704.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease*/etiology , Graft vs Host Disease*/metabolism , Hematopoietic Stem Cell Transplantation*/adverse effects , Mitochondria*/metabolism , Transplantation Conditioning*/methods, Animals ; Mice ; Humans ; Disease Models, Animal ; Antigen-Presenting Cells/metabolism ; Antigen-Presenting Cells/immunology

المؤلفون: Al-Jamaei AAH; Department of Oral and Maxillofacial Surgery, Amsterdam UMC, Amsterdam, The Netherlands.; Department of Oral Medicine, Periodontics, Diagnostic, and Oral Radiology, Faculty of Dentistry, Sanaá University, Sanaá, Yemen.; Department of Oral Surgery and Oral Medicine, Al-Razi University, Sanaá, Yemen., Epstein JB; Cedars-Sinai Medical Center, Los Angeles, CA, USA.; City of Hope Comprehensive Cancer Center, Duarte, CA, USA., de Visscher JGAM; Department of Oral and Maxillofacial Surgery, Amsterdam UMC, Amsterdam, The Netherlands., Spielberger RT; Department of BMT, Southern California Permanente Medical Group, Kaiser Permanente, Los Angeles, CA, USA.; Department of Hematology &, Center for Stem Cell Transplantation at City of Hope Comprehensive Cancer Center, Hematopoietic Cell Transplantation, Duarte, CA, USA., Nakamura R; Department of Hematology &, Center for Stem Cell Transplantation at City of Hope Comprehensive Cancer Center, Hematopoietic Cell Transplantation, Duarte, CA, USA., Raber-Durlacher JE; Department of Oral and Maxillofacial Surgery, Amsterdam UMC, Amsterdam, The Netherlands. j.raber.durlacher@acta.nl.; Department of Oral Medicine, Academic Centre for Dentistry Amsterdam, Amsterdam, The Netherlands. j.raber.durlacher@acta.nl.

المصدر: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Jul 17; Vol. 32 (8), pp. 519. Date of Electronic Publication: 2024 Jul 17.

نوع المنشور: Journal Article; Systematic Review; Meta-Analysis; Comparative Study; Review

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Graft vs Host Disease*/prevention & control , Graft vs Host Disease*/etiology , Stomatitis*/etiology , Stomatitis*/prevention & control , Methotrexate*/administration & dosage , Methotrexate*/therapeutic use , Methotrexate*/adverse effects , Immunosuppressive Agents*/administration & dosage , Immunosuppressive Agents*/adverse effects, Humans ; Randomized Controlled Trials as Topic ; Severity of Illness Index

المؤلفون: DeFilipp Z; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., Kim HT; Department of Data Science, Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health, Boston, MA., Spyrou N; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Katsivelos N; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Kowalyk S; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Eng G; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Kasikis S; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Beheshti R; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Baez J; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Akahoshi Y; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Ayuk F; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Choe H; Division of Hematology, James Cancer Center, The Ohio State University, Columbus, OH., Etra A; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Grupp SA; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA., Hexner EO; Blood and Marrow Transplantation Program, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Hogan WJ; Division of Hematology, Mayo Clinic, Rochester, MN., Kitko CL; Pediatric Stem Cell Transplant Program, Vanderbilt University Medical Center, Nashville, TN., Qayed M; Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA., Reshef R; Blood and Marrow Transplantation Program, Columbia University Medical Center, New York, NY., Vasova I; Department of Internal Medicine 5, Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany., Zeiser R; Department of Medicine I - Medical Centre, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Young R; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Holler E; Department of Hematology and Oncology, Internal Medicine III, University of Regensburg, Regensburg, Germany., Ferrara JLM; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Nakamura R; Hematology/Hematopoietic Cell Transplant, City of Hope National Medical Center, Duarte, CA., Levine JE; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Chen YB; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA.

المصدر: Blood advances [Blood Adv] 2024 Jul 09; Vol. 8 (13), pp. 3488-3496.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease*/drug therapy , Graft vs Host Disease*/etiology , Algorithms*, Humans ; Male ; Female ; Middle Aged ; Adult ; Treatment Outcome ; Nitriles/therapeutic use ; Pyrazoles/therapeutic use ; Pyrimidines/therapeutic use ; Aged ; Acute Disease ; Biomarkers ; Young Adult ; Adolescent ; Hematopoietic Stem Cell Transplantation/adverse effects

المؤلفون: Yeh AC; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA. Electronic address: ayeh@fredhutch.org., Koyama M; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Waltner OG; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Minnie SA; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Boiko JR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Shabaneh TB; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Takahashi S; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Zhang P; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Ensbey KS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Schmidt CR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Legg SRW; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Sekiguchi T; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Nelson E; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Bhise SS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Stevens AR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Goodpaster T; Experimental Histopathology Core, Fred Hutchinson Cancer Center, Seattle, WA, USA., Chakka S; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Furlan SN; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Markey KA; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA., Bleakley ME; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Division of Hematology, Oncology, and Bone Marrow Transplantation, Department of Pediatrics, University of Washington, Seattle, WA, USA., Elson CO; Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA., Bradley PH; Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Biochemistry and Institute for Protein Design, University of Washington, Seattle, WA, USA., Hill GR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA. Electronic address: grhill@fredhutch.org.

المصدر: Immunity [Immunity] 2024 Jul 09; Vol. 57 (7), pp. 1648-1664.e9. Date of Electronic Publication: 2024 Jun 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 9432918 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4180 (Electronic) Linking ISSN: 10747613 NLM ISO Abbreviation: Immunity Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease*/immunology , Graft vs Host Disease*/microbiology, Animals ; Mice ; Mice, Inbred C57BL ; CD4-Positive T-Lymphocytes/immunology ; Receptors, Antigen, T-Cell/immunology ; Receptors, Antigen, T-Cell/genetics ; Receptors, Antigen, T-Cell/metabolism ; Microbiota/immunology ; Clonal Selection, Antigen-Mediated ; Transplantation, Homologous ; Bayes Theorem ; Stem Cell Transplantation/adverse effects ; Mice, Inbred BALB C ; Gastrointestinal Microbiome/immunology ; Hematopoietic Stem Cell Transplantation/adverse effects

المؤلفون: Wei X; Department of Hematology, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China (mainland).; School of Medicine, Nankai University, Tianjin, China (mainland)., Huang S; Department of Hematology, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China (mainland)., Gu Z; Department of Hematology, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China (mainland)., Liu J; Department of Hematology, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China (mainland)., Li M; Department of Hematology, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China (mainland)., Jin X; Department of Hematology, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China (mainland)., Bo J; Department of Hematology, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China (mainland)., Li F; Department of Hematology, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China (mainland)., Jing Y; Department of Hematology, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China (mainland)., Gao X; Department of Hematology, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China (mainland)., Dou L; Department of Hematology, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China (mainland)., Liu D; Department of Hematology, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China (mainland)., Gao C; Department of Hematology, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China (mainland).

المصدر: Annals of transplantation [Ann Transplant] 2024 Jul 02; Vol. 29, pp. e943688. Date of Electronic Publication: 2024 Jul 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Scientific Literature, Inc Country of Publication: United States NLM ID: 9802544 Publication Model: Electronic Cited Medium: Internet ISSN: 2329-0358 (Electronic) Linking ISSN: 14259524 NLM ISO Abbreviation: Ann Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/adverse effects , Graft vs Host Disease*/genetics , Graft vs Host Disease*/etiology , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/therapy , Mutation* , Clonal Hematopoiesis*/genetics, Humans ; Male ; Female ; Middle Aged ; Adult ; Young Adult ; Adolescent ; DNA Methyltransferase 3A ; Dioxygenases ; DNA (Cytosine-5-)-Methyltransferases/genetics ; Aged ; Prognosis ; Transplantation, Homologous ; High-Throughput Nucleotide Sequencing ; DNA-Binding Proteins ; Repressor Proteins

المؤلفون: Li D; Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Cho MS; Section of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gonzalez-Delgado R; Section of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Liang X; Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center, Houston, Texas, USA., Dong JF; Bloodworks Research Institute and Hematology Division, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA., Cruz MA; Center for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey VA Medical Center, Houston, Texas, USA.; Baylor College of Medicine, Houston, Texas, USA.; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA., Ma Q; Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Afshar-Kharghan V; Section of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

المصدر: Journal of cellular and molecular medicine [J Cell Mol Med] 2024 Jul; Vol. 28 (13), pp. e18457.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print Cited Medium: Internet ISSN: 1582-4934 (Electronic) Linking ISSN: 15821838 NLM ISO Abbreviation: J Cell Mol Med Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease*/etiology , Graft vs Host Disease*/immunology , ADAMTS13 Protein*/metabolism , Mice, Inbred BALB C* , T-Lymphocytes*/immunology , T-Lymphocytes*/metabolism , Mice, Inbred C57BL* , von Willebrand Factor*/metabolism, Animals ; Mice ; Humans ; Transplantation, Homologous ; Hematopoietic Stem Cell Transplantation/adverse effects ; Disease Models, Animal ; Bone Marrow Transplantation ; Endothelial Cells/metabolism

المؤلفون: Dou Y; Key Laboratory of Immune Response and Immunotherapy, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China; Institute of Immunology, University of Science and Technology of China, Hefei, China., Nian Z; Key Laboratory of Immune Response and Immunotherapy, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China; Institute of Immunology, University of Science and Technology of China, Hefei, China., Wang D; Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230027, China; Blood and Cell Therapy Institute, Anhui Provincial Key Laboratory of Blood Research and Applications, University of Science and Technology of China, Hefei, Anhui, 230027, China., Sun G; Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230027, China; Blood and Cell Therapy Institute, Anhui Provincial Key Laboratory of Blood Research and Applications, University of Science and Technology of China, Hefei, Anhui, 230027, China., Zhou L; Department of Hematology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China., Hu Z; Key Laboratory of Immune Response and Immunotherapy, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China; Institute of Immunology, University of Science and Technology of China, Hefei, China., Ke J; Department of Obstetrics and Gynecology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China., Zhu X; Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230027, China; Blood and Cell Therapy Institute, Anhui Provincial Key Laboratory of Blood Research and Applications, University of Science and Technology of China, Hefei, Anhui, 230027, China., Sun R; Key Laboratory of Immune Response and Immunotherapy, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China; Institute of Immunology, University of Science and Technology of China, Hefei, China., Tian Z; Key Laboratory of Immune Response and Immunotherapy, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China; Institute of Immunology, University of Science and Technology of China, Hefei, China., Fu B; Key Laboratory of Immune Response and Immunotherapy, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China; Institute of Immunology, University of Science and Technology of China, Hefei, China. Electronic address: fbq@ustc.edu.cn., Zhou Y; Key Laboratory of Immune Response and Immunotherapy, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China; Institute of Immunology, University of Science and Technology of China, Hefei, China. Electronic address: ygzhou@ustc.edu.cn., Wei H; Key Laboratory of Immune Response and Immunotherapy, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China; Institute of Immunology, University of Science and Technology of China, Hefei, China. Electronic address: ustcwhm@ustc.edu.cn.

المصدر: Journal of autoimmunity [J Autoimmun] 2024 Jul; Vol. 147, pp. 103274. Date of Electronic Publication: 2024 Jun 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Academic Press Country of Publication: England NLM ID: 8812164 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9157 (Electronic) Linking ISSN: 08968411 NLM ISO Abbreviation: J Autoimmun Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease*/etiology , Graft vs Host Disease*/immunology , Killer Cells, Natural*/immunology , Killer Cells, Natural*/metabolism , Bone Marrow Transplantation*/adverse effects , Transplantation, Homologous*, Animals ; Mice ; Humans ; Chronic Disease ; Male ; Female ; Histocompatibility Antigens Class II/immunology ; Histocompatibility Antigens Class II/metabolism ; Disease Models, Animal ; Hematopoietic Stem Cell Transplantation/adverse effects ; Mice, Inbred C57BL ; Immune Reconstitution ; Bronchiolitis Obliterans Syndrome

المؤلفون: Cordón L; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain. lou.cordon@gmail.com.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain. lou.cordon@gmail.com., Chorão P; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain.; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Martín-Herreros B; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain., Montoro J; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Balaguer A; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain.; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Guerreiro M; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain.; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Villalba M; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain.; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Facal A; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain.; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Asensi P; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Solves P; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Gómez I; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Santiago M; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain.; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Lamas B; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Bataller A; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Granados P; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Sempere A; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Sanz GF; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Sanz MA; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Sanz J; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.

المصدر: Annals of hematology [Ann Hematol] 2024 Jul; Vol. 103 (7), pp. 2475-2484. Date of Electronic Publication: 2024 Apr 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Transplantation Conditioning*/methods , Hematologic Neoplasms*/therapy , Cord Blood Stem Cell Transplantation*/methods , Antilymphocyte Serum*/therapeutic use , Graft vs Host Disease*/etiology , Graft vs Host Disease*/prevention & control , Immune Reconstitution*, Humans ; Female ; Male ; Adult ; Middle Aged ; Aged ; Young Adult ; Adolescent ; Killer Cells, Natural/immunology ; Myeloablative Agonists/therapeutic use